Agenda and keynote details now available for the premier annual event advancing health data sharing, health improvement, and ...

A live video webcast of the presentation will be available to the general public and can be accessed at https://investors.alvotech.com/events/event-details/jefferies-global-hea.... After the event, a ...

(Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatological or neurological ...

GvHD is a severe immune complication that can occur after allogeneic HSCT, often leading to multi-organ damage and high mortality. iNKT cells are uniquely suited for this setting due to their natural ...

Solera Health, the premier digital health delivery company creating flexible solutions to seamlessly connect people to on-benefit care via health plans and employers, today announced the launch of its ...

This five-year analysis of the C-144-01 trial represents unprecedented durability and duration of follow-up in advanced melanoma patients previously treated with anti-PD-1 and targeted therapy, where ...

Company to outline vision and showcase foundation for accelerated innovation later this week at 62nd ERA Congress in Vienna, Austria VIENNA, June 02, 2025 (GLOBE NEWSWIRE) -- Vantive, a vital organ ...

Clean Air Day is a timely reminder that air pollution not only threatens ecosystems and wildlife but also takes a serious toll on human health. As wildfire season intensifies across the country, the ...

MONSTAR-SCREEN-3 study showed 100% detection of circulating tumor DNA (ctDNA) at baseline timepoint, and 60% of patients testing positive one month after surgery had tumor fractions only detectable ...

These senior leaders highlight Cytrellis’ commitment to clinical innovation, commercial excellence, and scalable growth. They bring extensive experience in aesthetics and life sciences and will play a ...

As we move from concept to completion, the ‘Labs’ part of Liberation Labs felt unnecessarily limiting, if not outright confusing,” said Mark Warner, founder and CEO of Liberation Bioindustries. “After ...

"The Evosep Eno is a key component of the next generation LC-MS based proteomics workflows. Its capabilities will empower researchers to uncover new insights and drive progress in drug discovery and ...